Contact Points
Pleasanton, California, 94588-3260
These kits are the key component to profile cell types and identify novel targets with single cell RNA-seq in the central nervous system of patients with progressive multifocal leukoencephalopathy (PML). The goal of this study is to characterize the mechanism of action of experimental immune reconstitution treatment approaches for PML; to investigate the pathogenesis of PML, including the mechanisms of tissue injury and repair and their correlation to findings on MRI; and to characterize features of the immunological predisposition and recovery.
Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.